Advanced Biomed (ADVB) said Thursday it priced its initial public offering of 1.6 million shares at $4 per share, for expected gross proceeds of about $6.6 million.
The shares have been approved for listing on Nasdaq and are expected to start trading on Thursday under the ticker "ADVB," the company said.
Underwriters have been given a 45-day option to buy up to an additional 246,000 shares, Advanced Biomed said.
The offering is expected to close on or about Friday, it said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。